@deemno.bsky.social
From pathogen detection to treatment optimization, AI is reshaping infectious disease research. OFID wants your breakthrough work. Nov 2 deadline.
Learn more ⬇️
Learn more ⬇️
Joint Call for Papers: Leveraging AI Technologies for Discoveries and Solutions in Infectious Diseases
The IDSA journals are seeking papers focused on artificial intelligence (AI) and how it enhances and impacts infectious diseases. The journals are interested in
bit.ly
November 16, 2025 at 10:32 PM
Risk factors for Lyme disease in the general population - a survey of adults and caregivers in 28 states
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4hCops2
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4hCops2
November 16, 2025 at 10:32 PM
Projected Increases in Older People with HIV in the United States through 2040
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4oK9X3u
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4oK9X3u
November 16, 2025 at 10:31 PM
Epidemiology of brain abscess: A retrospective cohort from a neurosurgical tertiary referral centre in England
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Wu0PE1
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Wu0PE1
November 16, 2025 at 10:31 PM
A Quality Improvement Pilot to Increase Hepatitis B Screening and Optimize Patient Selection for Switch to Two-Drug Antiretroviral Regimens in People with HIV
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48QNZqJ
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48QNZqJ
November 16, 2025 at 10:31 PM
Lenacapavir Plus Cabotegravir as Combination Treatment: Real-world Use Cases from the National Clinician Consultation Center
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Jz9KRA
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Jz9KRA
November 16, 2025 at 10:31 PM
Sustained HIV suppression with co-formulated tenofovir disoproxil fumarate/lamivudine/dolutegravir in a person with transmitted dolutegravir resistance and pre-treatment resistance to lamivudine: a case report from HPTN 083
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4oxIGRA
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4oxIGRA
November 16, 2025 at 10:31 PM
Off-label use of gastrointestinal multiplex PCR panel for the diagnosis of amoebic liver abscess. A three-case pediatric report.
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4oJIv5X
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4oJIv5X
November 16, 2025 at 10:31 PM
Susceptibility of measles virus to WHO hand rubs, oral and surface disinfectants
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47m4OaP
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47m4OaP
November 16, 2025 at 10:31 PM
Female sex is protective against MASLD with clinically significant fibrosis in a large cross-sectional cohort of persons with HIV
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Female sex is protective against MASLD with clinically significant fibrosis in a large cross-sectional cohort of persons with HIV
Men are at higher risk for metabolic dysfunction-associated steatotic liver disease (MASLD) with clinically significant fibrosis (CSF) than pre-menopausal women, but data are lacking in persons with HIV (PWH).
bit.ly
November 16, 2025 at 10:31 PM
Evaluation of the performance of stool samples to diagnose pediatric pulmonary tuberculosis in routine care: a cohort study from Pakistan
✅ Just Accepted
#IDSky
🔗 https://bit.ly/42RAkfp
✅ Just Accepted
#IDSky
🔗 https://bit.ly/42RAkfp
November 16, 2025 at 10:31 PM
"ProTeggiMI": Adherence to HIV vertical transmission prevention pathway in remote communities in Mozambique
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47AXLMx
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47AXLMx
November 16, 2025 at 10:31 PM
Long-term outcomes of young adults with perinatal HIV infection in the U.S. and Puerto Rico
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4qeZj6s
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4qeZj6s
November 16, 2025 at 10:30 PM
Changes in body mass index in children and adolescents living with HIV in Europe and Thailand starting dolutegravir
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48zBrUJ
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48zBrUJ
November 16, 2025 at 10:30 PM
Response to letter to the editor regarding A Rapid Systematic Review of U.S. Food and Drug Administration-Authorized Coronavirus Disease 2019 Treatments
✅ Just Accepted
#IDSky
🔗 https://bit.ly/475Khah
✅ Just Accepted
#IDSky
🔗 https://bit.ly/475Khah
November 16, 2025 at 10:30 PM
Letter to editor about A Rapid Systematic Review of U.S. Food and Drug Administration-Authorized COVID-19 Treatments
✅ Just Accepted
#IDSky
🔗 https://bit.ly/475tILH
✅ Just Accepted
#IDSky
🔗 https://bit.ly/475tILH
November 16, 2025 at 10:30 PM
Effectiveness and safety of antibiotics in kidney transplant recipients with asymptomatic bacteriuria: a systematic review and meta-analysis of randomised controlled trials
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Effectiveness and safety of antibiotics in kidney transplant recipients with asymptomatic bacteriuria: a systematic review and meta-analysis of randomised controlled trials
Asymptomatic bacteriuria (ASB) is generally systematically screened and treated with antibiotics in kidney transplant recipients (KTRs).
doi.org
November 11, 2025 at 9:10 AM
Impact of delays in diagnosis on healthcare costs associated with blastomycosis, coccidioidomycosis, and histoplasmosis in a commercially insured population
✅ Just Accepted
⭐ Editor's Choice
#IDSky
✅ Just Accepted
⭐ Editor's Choice
#IDSky
Impact of delays in diagnosis on healthcare costs associated with blastomycosis, coccidioidomycosis, and histoplasmosis in a commercially insured population
Among patients with blastomycosis (n=281), coccidioidomycosis (n=1,920), and histoplasmosis (n=2,180), 62% experienced diagnostic delays (mean 26 days). Patients who experienced delays incurred average excess healthcare costs of up to $15,648 (95% confidence interval: $8,600–$22,695) compared to...
bit.ly
November 11, 2025 at 9:10 AM
Antimicrobial usage among acutely ill hospitalised children aged 2-23 months in sub-Saharan Africa and South Asia
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Antimicrobial usage among acutely ill hospitalised children aged 2-23 months in sub-Saharan Africa and South Asia
Understanding patterns of antimicrobial use is critical to supporting antibiotic stewardship and limiting antimicrobial resistance (AMR).
bit.ly
November 11, 2025 at 9:10 AM
Development and Validation of a Machine Learning?Based Screening Algorithm to Predict High-Risk Hepatitis C Infection
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Development and Validation of a Machine Learning–Based Screening Algorithm to Predict High-Risk Hepatitis C Infection
Our machine learning-based screening algorithm improves HCV detection efficiency, optimizing resource allocation and supporting timely diagnosis and treatm
doi.org
September 9, 2025 at 5:35 PM
Bacteremic vs Nonbacteremic Shigella Infections in the United States Veterans Health Administration, 2000 ? 2024
✅ Just Accepted
⭐ Editor's Choice
#IDSky
✅ Just Accepted
⭐ Editor's Choice
#IDSky
Bacteremic vs Nonbacteremic Shigella Infections in the United States Veterans Health Administration, 2000–2024
AbstractBackground. Risk factors for Shigella bacteremia are poorly understood. Growing trends in antimicrobial resistance may make treatment of Shigella...
doi.org
September 9, 2025 at 5:35 PM
Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream Infections
✅ Just Accepted
https://bit.ly/426MyQH
✅ Just Accepted
https://bit.ly/426MyQH
Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream Infections
Extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) hydrolyze most β-lactam antibiotics, with the general exception of carbapenems.
bit.ly
September 9, 2025 at 5:34 PM
Changes in the prevalence of antimalarial partner drug resistance markers and policy in six sub-Saharan African countries from 2000 to 2021: A systematic review
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Changes in the prevalence of antimalarial partner drug resistance markers and policy in six sub-Saharan African countries from 2000 to 2021: A systematic review
Prompt malaria case management is a cornerstone for malaria control and elimination. However, this strategy is threatened by the development of antimalarial drug resistance.
bit.ly
September 9, 2025 at 5:32 PM
